Skip to content
Unrated Drug recall · FDA · Published October 19, 2015

Oasis Medical Recalls HPMC Visoelastic Syringes Due to pH Failure

Oasis Medical recalls 3,358 units of HPMC Visoelastic Topical syringes because the pH may not meet specifications at expiry. Check lot numbers V1014M, V1214B, and V0415H.

🇺🇸 FDA recall #D-0523-2016DrugOasis Medical ›
Take action

Contact the company

Recalling firmOasis Medical, Inc.514 S. Vermont Ave Bldg 510-528 · Glendora, CA 91741-6205
✎ GovInfoNow plain-language explainer

Oasis Medical, Inc. is recalling HPMC Visoelastic Topical solution in 3-mL syringes because the pH of the product may not meet specifications at expiry. The recall affects 3,358 units distributed nationwide and internationally. No remedy or injury reports are listed in the record. Read more at govinfonow.com/recall/43479-oasis-medical-inc-recalls-hpmc-visoelastic-topical-8-000-cps.

Source Summary by GovInfoNow · govinfonow.com/recall/43479-oasis-medical-inc-recalls-hpmc-visoelastic-topical-8-000-cps · Updated October 11, 2026 · FDA enforcement record: FDA #D-0523-2016

Cite this page

“Oasis Medical Recalls HPMC Visoelastic Syringes Due to pH Failure.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/43479-oasis-medical-inc-recalls-hpmc-visoelastic-topical-8-000-cps. Based on FDA recall #D-0523-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0523-2016%22&limit=1).

Oasis Medical, Inc. recalled HPMC Visoelastic Topical Syringe units due to failed pH specifications, the FDA said on Oct. 19, 2015. The agency announced the Class III recall of 3,358 units distributed nationwide and internationally.

How to tell if you have it

  • Brand: Oasis Medical
  • Product: HPMC Visoelastic Topical Syringe
  • Reference: 5200
  • Concentration: 8,000 cps
  • Volume: 1.5 mL in 3-mL Syringe
  • Lot #: V1014M, Exp 10/2016; V1214B, Exp 12/2016; V0415H, Exp 4/2017

The hazard

The FDA determined that the pH of the recalled lots may not meet specification at expiry. The recall is classified as Class III.

Context

GovInfoNow's records show Oasis Medical, Inc. has four other recalls on record since May 14, 2014. Other recent recalls of similar products include Sun Pharmaceutical Diclofenac Gel Recall (Jan. 27, 2026), Sun Pharmaceutical Fluocinonide Cream Recall (March 25, 2026), and Water-Jel Lidocaine Wound Gel Recall (April 7, 2026).

How to tell if you have this one

Look for HPMC Visoelastic Topical, 8,000 cps, Reference 5200, in a 1.5 mL volume within a 3-mL syringe. Check the lot numbers: V1014M (Exp 10/2016), V1214B (Exp 12/2016), or V0415H (Exp 4/2017). The product was distributed in the U.S. and several other countries.

  • Brand
    Oasis Medical
  • Category
    Drug
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Terminated
  • Distribution
    Nationwide and Saudi Arabia, Israel, Chile, Norway, Ecuador, Greece, Switzerland, Canada, England, Columbia, Poland, South Africa, Germany, Pakistan, El Salvador, Dubai, Belgium
Recall numberProduct, codes & lotsQuantity
D-0522-2016HPMC Visoelastic, 20,000 cps, Reference 5122, 515 (Private Label), 600102-001 (Private Label), 600103-001 (Private Label), 2.0 mL in 3-mL Syringe, OASIS Medical Inc, 514 South Vermont Avenue Glendora, CA 91741; Lot #: V0814H, V0814J, Exp 08/2016; V1014L, Exp 11/2016; V1114A, Exp 11/2016; V0115G, V0115H, Exp 01/2017; V0215A, V0215B, Exp 02/2017; V0315G, V0315H, V0315O, Exp 03/2017; V0515C, V0515D, Exp 05/2017.15,301 units
D-0523-2016HPMC Visoelastic Topical, 8,000 cps, Reference 5200, 1.5 mL in 3-mL Syringe, OASIS Medical Inc, 514 South Vermont Avenue Glendora, CA 91741; Lot #: V1014M, Exp 10/2016; V1214B, Exp 12/2016; V0415H, Exp 4/2017.3,358 units
D-0524-2016HPMC Visoelastic, 8,000 cps, Reference 51082, LT5108 (Private Label), 2.0 mL in 3-mL Syringe, OASIS Medical Inc, 514 South Vermont Avenue Glendora, CA 91741; Lot #: V0814C, V0814D, Exp 8/2016; V1014A, V1014B, Exp 10/2016; V1214C, Exp 12/2016; V0115A, V0115B, Exp 01/2017; V0215C, Exp 02/2017; V0315C, V0315D, Exp 03/2017; V0515A, V0515B, Exp 05/2017.14,852 units
Based on the official FDA remedy

What to do — step by step

  1. Check your syringe

    Verify if your product matches the brand, lot numbers, and expiration dates listed in the recall record.

  2. Contact the manufacturer

    Since no remedy is stated in the record, contact Oasis Medical, Inc. at 514 South Vermont Avenue, Glendora, CA 91741 for further instructions.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide and Saudi Arabia, Israel, Chile, Norway, Ecuador, Greece, Switzerland, Canada, England, Columbia, Poland, South Africa, Germany, Pakistan, El Salvador, Dubai, Belgium” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 5 months after the firm started it.

1. Firm started the recall: Oct 19, 201512. FDA classified it Class III: Dec 22, 201523. Published in FDA’s Enforcement Report: Dec 30, 201534. FDA terminated the recall: Mar 14, 2016420152016
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Where was this product sold?

It was distributed nationwide in the U.S. and in Saudi Arabia, Israel, Chile, Norway, Ecuador, Greece, Switzerland, Canada, England, Columbia, Poland, South Africa, Germany, Pakistan, El Salvador, Dubai, and Belgium.

Similar recalls

Other Oasis Medical recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0523-2016 (October 19, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0523-2016 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA